CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
pharmacokinetic (PK), pharmacodynamic (PD), and the preliminary efficacy of JANX007 in adults with metastatic castration-resistant prostate ...
Phase 1
Jacksonville, Florida, United States and 35 other locations
with prostate cancer who received at least one dose of AAA617 from interventional, Phase I-IV Novartis sponsored clinical trials....
Phase 4
Jacksonville, Florida, United States and 53 other locations
of the Vanquish Water Vapor Ablation Device ("Vanquish") in treating subjects with Gleason Grade Group 2 (GGG2) localized intermediate-risk prostate...
Jacksonville, Florida, United States and 24 other locations
with high-risk and very high-risk localised/locally advanced prostate cancer with a breast cancer gene mutation (BRCAm)....
Phase 3
Jacksonville, Florida, United States and 341 other locations
The purpose of this study is to evaluate the efficacy and safety of apalutamide in adult men with high-risk non-metastatic castration-resistant prostate...
Phase 3
Jacksonville, Florida, United States and 378 other locations
The aim for this study is to assess the diagnostic performance of 64Cu-SAR-bisPSMA PET to detect regional nodal metastases.
Phase 3
Jacksonville, Florida, United States and 31 other locations
The primary purpose of this study is to evaluate the safety, tolerability, and efficacy of SYNC-T Therapy SV-102 and to identify the maximum tolerate...
Phase 2
Jacksonville, Florida, United States and 22 other locations
of tulmimetostat (DZR123) and JSB462 (luxdegalutamide) versus standard of care in participants with progressive metastatic castrate resistant prostate...
Phase 1, Phase 2
Jacksonville, Florida, United States and 33 other locations
prednisone in treating patients with castration-resistant metastatic prostate cancer. Androgens can cause the growth of prostate...
Phase 3
Jacksonville, Florida, United States and 538 other locations
vipivotide tetraxetan (AAA617) in participants with oligometastatic prostate cancer (OMPC) progressing after definitive therapy to ...
Phase 3
Jacksonville, Florida, United States and 143 other locations
Clinical trials
Research sites
Resources
Legal